Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases: A Step Towards Precision Medicine

NCT07248371 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.

NCT NCT07248371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07248371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases: A Step Towards Precision Medicine
Lead sponsor
Chang Gung Memorial Hospital
Phase
Observational
Overall status
Recruiting
Start date
June 9, 2025
Completion date
September 30, 2035
Enrollment
6,266 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases (cvd), chronic kidney disease, healthy, metabolic syndrome (mets), nonalcoholic fatty liver disease, obesity & overweight